NAIL FUNGUS TREATMENT

Manufacturer
Shenzhen Bullfighting Trading Co., Ltd.
Effective date
2025-06-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:06:00

Label at a glance#

ProductNAIL FUNGUS TREATMENT
Active ingredientTOLNAFTATE
Label structure14 sections

Dosage and administration

Soak the affected nail inwarm water to soften it. Gently file thenail to thin it and remove dirt, beingcautious not to harm the nail bed. Application: Apply full layers of thesolution with the brush onto affectedareas on, around, and under the nails.A light tingle or burn is normal for thefirst 10 minutes until absorbed. Frequency: Use twice daily (morningand night). Visible results may appearin 6 weeks. Continue ...

Storage and handling

Store between 15°C to 30'C(59'F to86°F). Avoid freezing and excessiveheat above 40°C (104°F).

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Use

INDICATIONS & USAGE SECTION

For the effective treatment of nailfungus, discoloration, thickening,splitting, crumbling, and brittleness.

Warnings

WARNINGS SECTION

Avoid contact with eyes, mouth, andopen wounds. Rinse immediately ifexposed.If irritation persists, seekmedical help.keep out of reach ofchildren and pets.

Do not use

OTC - DO NOT USE SECTION

On damaged skin (cuts, abrasions,eczema, sunburn).

lfyou have diabetes or poor bloodcirculation.

When Using

OTC - WHEN USING SECTION

Skin discoloration may occur during or after use.

Stop Use

OTC - STOP USE SECTION

If irritation occurs. If an allergic reaction occurs.

Ask Doctor

OTC - ASK DOCTOR SECTION

if you are pregnant or breastfeeding.
if you have diabetes.

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children and pets.

If swallowed, get medical help or contact a Poison Control Center immediately (1-800-222-1222).
Children should use under adult supervision.

Directions

DOSAGE & ADMINISTRATION SECTION

Soak the affected nail inwarm water to soften it. Gently file thenail to thin it and remove dirt, beingcautious not to harm the nail bed.
Application: Apply full layers of thesolution with the brush onto affectedareas on, around, and under the nails.A light tingle or burn is normal for thefirst 10 minutes until absorbed.
Frequency: Use twice daily (morningand night). Visible results may appearin 6 weeks. Continue regular use toprevent regrowth.

Other information

STORAGE AND HANDLING SECTION

Store between 15°C to 30'C(59'F to86°F). Avoid freezing and excessiveheat above 40°C (104°F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

Euphorbia hirta whole, Glycerin, Hydracrylic Acid, Pseudolarix amabilis bark, Resorcinol, Water

Questions

OTC - QUESTIONS SECTION

Email: douniu1@outlook.com

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
313423tolnaftate 1 % Topical SolutionPSN1
313423tolnaftate 10 MG/ML Topical SolutionSCD1
313423tolnaftate 1 % Topical SolutionSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85834-001-01NAIL FUNGUS TREATMENT30 mL in 1 BOTTLELIQUID301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85834-00185834-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
38c2639f-43dc-d05c-e063-6394a90a0bc838c2639f-43db-d05c-e063-6394a90a0bc82025-06-29WarningsExact identifier
spl id: 38c2639f-43dc-d05c-e063-6394a90a0bc8
spl set id: 38c2639f-43db-d05c-e063-6394a90a0bc8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.